Trademark Overview
On Tuesday, July 10, 2001, a trademark application was filed for EPZELIAL with the United States Patent and Trademark Office. The USPTO has given the EPZELIAL trademark a serial number of 76282340. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, February 10, 2003. This trademark is owned by Human Genome Sciences, Inc.. The EPZELIAL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in promoting the growth and repair of epithelial cells; pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone morrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders, connective tissue disorders, critical care, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, immunologic conditions, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurologic disorders, nutritional disorders, obstetric, gynecological and reproductive disorders, oncologic conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, poisoning, psychiatric disorders, respiratory diseases, dermatologic disorders, substance abuse disorders, thrombotic diseases, vascular diseases, tendon and muscular injuries, back inj...
